For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after ...

Celltrion’s biosimilar marketing strategy in Europe has got seriously confusing after the firm asked to market its rituximab near-copy under four different brands. Its biosimilar of Roche’s ...

An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...

The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

PET-guided biopsy from the infrarenal mass was suggestive of unicentric Castleman disease (UCD). She was managed with local surgical resection, steroids and rituximab. The current case highlights that ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter ...

Limited (“HUTCHMED”, the “Company” or “we”) (HKEX:13; Nasdaq/AIM:HCM) today reports its financial results for the year ended December 31, 2024 and provides updates on key clinical and commercial ...

2025年3月19日，知名商业媒体《快公司》（Fast Company）公布了 “全球最具创新力的10家医药公司”。它们 ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

After hours: March 17 at 6:54:36 PM EDT Loading Chart for BLRX ...

难治性全身型重症肌无力（generalized ...